Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0007 Transporter Info | ||||
| Gene Name | SLC47A1 | ||||
| Transporter Name | Multidrug and toxin extrusion protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Tubocurarine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 6000 | ||||
| Docking Score | -8.482 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C37H41N2O6+ | ||||
| Molecular Weight | 609.7 | ||||
| Canonical SMILES |
CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC
|
||||
| InChI |
InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1
|
||||
| InChIKey | JFJZZMVDLULRGK-URLMMPGGSA-O | ||||
| Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 2 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Crizotinib Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 11626560 | ||||
| Docking Score | -8.477 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H22Cl2FN5O | ||||
| Molecular Weight | 450.3 | ||||
| Canonical SMILES |
C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
|
||||
| InChI |
InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
|
||||
| InChIKey | KTEIFNKAUNYNJU-GFCCVEGCSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Erythromycin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 12560 | ||||
| Docking Score | -8.439 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C37H67NO13 | ||||
| Molecular Weight | 733.9 | ||||
| Canonical SMILES |
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
|
||||
| InChI |
InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
|
||||
| InChIKey | ULGZDMOVFRHVEP-RWJQBGPGSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.7 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 14 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.